Table 3. Association between HBV,HCV and HIV infections and certain influencing variables among Tripoli population.
HCV | HBsAg | HIV | |||||||
OR | 95.0% C.I. | OR | 95.0% C.I. | OR | 95.0% C.I. | ||||
Lower | Upper | Lower | Upper | Lower | Upper | ||||
Age group | |||||||||
16–20 | 0.53 | 0.34 | 1.12 | 1.12 | 0.67 | 1.24 | 0.41 | 0.29 | 1.01 |
21–25 | 0.70 | 0.43 | 1.02 | 2.89 | 1.95 | 3.95 | 0.60 | 0.35 | 0.95 |
26–30 | 0.67 | 0.45 | 1.02 | 2.91 | 2.21 | 3.9 | 0.59 | 0.39 | 0.91 |
31–35 | 1.23 | 1.02 | 1.85 | 3.02 | 2.12 | 4.11 | 1.04 | 1.01 | 1.62 |
36–40 | 1.56 | 1.22 | 2.43 | 3.55 | 2.30 | 4.97 | 1.37 | 1.01 | 2.06 |
41–45 | 1.25 | 1.44 | 2.87 | 3.3 | 2.25 | 4.88 | 1.07 | 1.02 | 2.08 |
46–50 | 2.16 | 1.15 | 3.82 | 3.12 | 1.95 | 4.94 | 2.04 | 1.01 | 3.02 |
>51 | 2.21 | 1.01 | 4.38 | 5.58 | 3.23 | 8.95 | 2.02 | 0.94 | 4.05 |
Males vs females | 0.75 | 0.63 | 0.89 | 1.62 | 1.46 | 1.79 | 1.71 | 1.68 | 1.98 |
Blood transfusion | 1.22 | 1.12 | 1.87 | 0 | 0 | 0 | 0 | 0 | 0 |
Intravenous drug use | 6.31 | 2.15 | 17.15 | 0 | 0 | 0 | 5.65 | 1.75 | 17.06 |
Surgical exposure | 1.21 | 1.05 | 1.43 | 0 | 0 | 0 | 0 | 0 | 0 |
Family HBV | 1.12 | 1.1 | 1.90 | 1.65 | 1.34 | 2.54 | 0 | 0 | 0 |
Haemodialysis | 3.89 | 1.81 | 10.40 | 0 | 0 | 0 | 0 | 0 | 0 |
Contact with HBV | 1.51 | 1.12 | 2.13 | 0 | 0 | 0 |